REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 37.58B KRW in the quarter ending September 30, 2025, a decrease of -1.86%. This brings the company's revenue in the last twelve months to 149.34B, down -0.33% year-over-year. In the year 2024, REYON Pharmaceutical had annual revenue of 148.30B, down -1.83%.

Revenue (ttm)

149.34B

Revenue Growth

-0.33%

P/S Ratio

1.48

Revenue / Employee

339.42M

Employees

312

Market Cap

220.46B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	148.30B	-2.77B	-1.83%
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%
Dec 31, 2020	130.03B	-1.52B	-1.16%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2012	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5,504.84B
Celltrion	3,895.99B
ALTEOGEN	202.18B
ABL Bio	88.44B
SK Biopharmaceuticals	675.41B
Yuhan	2,136.67B
LigaChem Biosciences	159.27B
Peptron	6.19B

Revenue Rankings